Search PubMed⌕ Search

Biomedical subjects

D Pearson

Publications and source records attributed to D Pearson.

At least 163 records · Page 9Linked to original sources
PubMed1982

Strain restricted typing sera (SRTS) for use in monitoring the genetic integrity of congenic strains.

A relatively simple procedure for serologic monitoring of the genetic integrity of congenic strains housed in a conventional colony is presented. Using a combination of 3 or 4 F1 immunizing cells, sera can be produced in each strain housed in the colony which will react in a complement-mediated cytotoxicity assay with peripheral lymphocytes from most if not all other strains in the colony. Routine screening of breeding stock with these strain restricted typing sera (SRTS) permits the sensitive detection of genetic contamination between the stocks maintained. These sera detect H-2, minor histocompatibility differences, and other cell surface differentiation antigens, and can also be used to identify the nature of a contaminant when isolated. In addition, when used within appropriate strain combinations, the sera can be useful in detecting antigenic determinants otherwise difficult to identify.

Animals↗
PubMed1982

Evaluation of digitalis in cardiac failure.

Ten patients in sinus rhythm with symptomatic cardiac failure participated in a study investigating the value of digitalis at rest and during dynamic exercise. A haemodynamic profile and left ventricular ejection fraction were measured before treatment, after intravenous ouabain, and after six weeks of maintenance treatment with digoxin. There was no significant change in the haemodynamic profile or in the left ventricular ejection fraction at rest after either glycoside. During exercise there was a significant reduction in left ventricular filling pressure from 39 +/- 3 mm Hg to 34 +/- 3 mm Hg (p less than 0.05) after ouabain and to 33 +/- 3 mm Hg (p less than 0.02) after digoxin. Cardiac index improved from 33 +/- 0.3 1/min/m2 to 4.0 +/- 0.4 l/min/m2 (p less than 0.01) after ouabain and to 3.8 +/- 0.4 l/min/m2 (p less than 0.01) after digoxin. During exercise stroke volume index and stroke work index also improved significantly with both glycosides. This was accompanied by an increase in left ventricular ejection fraction from 29 +/- 2% to 36 +/- 3% (p less than 0.05) after ouabain and digoxin. In this study both intravenous ouabain and maintenance treatment with oral digoxin exerted a modest positive inotropic effect in patients with cardiac failure in sinus rhythm. The haemodynamic benefit, however, was manifest only during exertion.

Adult↗
PubMed1982

Nonsense suppression in Schizosaccharomyces pombe: the S. pombe Sup3-e tRNASerUGA gene is active in S. cerevisiae.

The gene encoding the efficient UGA suppressor sup3-e of Schizosaccharomyces pombe was isolated by in vivo transformation of Saccharomyces cerevisiae UGA mutants with S. pombe sup3-e DNA. DNA from a clone bank of EcoRI fragments from a S. pombe sup3-e strain in the hybrid yeast vector YRp17 was used to transform the S. cerevisiae multiple auxotroph his4-260 leu2-2 trp1-1 to prototrophy. Transformants were isolated at a low frequency; they lost the ability to grow in minimal medium after passaging in non-selective media. This suggested the presence of the suppressor gene on the non-integrative plasmid. Plasmid DNA, isolated from the transformed S. cerevisiae cells and subsequently amplified in E. coli, transformed S. cerevisiae his4-260 leu2-2 trp1-1 to prototrophy. In this way a 2.4 kb S. pombe DNA fragment carrying the sup3-e gene was isolated. Sequence analysis revealed the presence of two tRNA coding regions separated by a spacer of only seven nucleotides. The sup3-e tRNASerUGA tRNA gene is followed by a sequence coding for the initiator tRNAMet. The transformation results demonstrate that the cloned S. pombe UGA suppressor is active in S. cerevisiae UGA mutant strains.

Ascomycota↗
PubMed1982

Gross and cellular response of intestinal crypts to single and fractionated doses of vincristine plus radiation: the influence of time between modalities.

The response of intestinal crypts to single doses and four equal, daily fractions of vincristine (VCR) plus gamma-rays, has been measured by the crypt microcolony assay. Measurements were made for VCR given either 7 hours or 1 min before radiation. For the 7-hour interval, fractionating the VCR dose markedly increased the efficacy of the combination treatment. However at 1-min interval, no injury additional to that for gamma-rays alone could be demonstrated, with either one or four fractions. Histopathological studies showed that both VCR and gamma-rays alone caused cell death, but with different distributions in the crypt. For combined treatments, both VCR-and gamma-type damage could be recognized with the 7-hour interval, but at 1 min only gamma damage. It is suggested that mitotic delay induced by radiation may permit the repair of injury caused by simultaneously-delivered VCR.

Animals↗
PubMed1982

Interferences in in vivo neutron activation analysis.

Significant errors can occur in the measurement of the total amounts of N, P, Cl, Na, Ca and K in the human body by in vivo neutron activation analysis because of the presence of interfering activity in the gamma-ray energy spectrum. The interfering activity may be present for two reasons: firstly, patients may have received an administered radioisotope in an unrelated investigation; secondly, activation of elements not normally present in the body in large quantities may have occurred. The size and duration of these errors have been examined for two administered radioisotopes, 67Ga and 47Ca. The interferences due to activated iron and chromium from stainless steel prostheses have been examined, as well as those due to activated iodine and barium in radiographic contrast media. A description of the method by which we correct for those interferences is given. The effects of the shape of the standard spectra used in least squares analysis of the results have been examined.

Activation Analysis↗
PubMed1982

Chemical synthesis of urotensin II, a somatostatin like peptide in the caudal neurosecretory system of fishes.

In the goby, Gillichthys mirabilis, urotensin II (a bioactive neuropeptide present in the urophysis of teleost fish) has the dodecapeptide sequence, H2N-AGTADC-FWKYCV-OH, which is homologous with mammalian somatostatin at positions 1, 2 and 7-9. The Merrifield solid phase synthesis of Gillichthys urotensin II (UII) was accomplished by stepwise assembly from the carboxy terminus using N-alpha-tert, butyloxycarbonyl (Boc) amino acids containing benzyl-derived groups for protection of side-chain functionalities, Coupling of amino acids to the growing peptide was mediated by diisopropylcarbodiimide (DIC) in the presence of 1-hydroxybenzotriazole (HOBt). Residual alpha-amino groups remaining after coupling were blocked by acetylation with 1-acetylimidazole. Crude, synthetic UII was extracted from the HF-treated, protected peptide-resin product, reduced with dithiothreitol (DTT), reoxidized at high dilution with O2, and separated into its components using a single, preparative, reverse-phase HPLC step. The pure, synthetic UII, obtained in 7.6% yield from oxidized crude UII, was indistinguishable from pure, native UII in specific bioactivity, amino acid sequence, and retention time in each of two different HPLC systems.

Amino Acid Sequence↗
PubMed1982

Cardiovascular effects of prenalterol on rest and exercise haemodynamics in patients with chronic congestive cardiac failure.

?The cardiovascular effects of the cardioselective beta, agonist prenalterol have been studied in nine patients with severe chronic congestive cardiac failure and in six patients with left ventricular dysfunction resulting from previous myocardial infarction. In the patients with cardiac failure intravenous prenalterol in a dosage of 1.5 microgram/kg bodyweight increased the cardiac index from 1.8 +/- 0.1 to 21.+/- 0.1 1/min per m2 and the left ventricular ejection fraction from 22 +/- 3 to 28 +/- 3%. There was a modest but significant increase in heart rate from 76 +/- 3 to 87 +/- 4 beats/min. Systemic vascular resistance fell from 2285 +/- 51 to 2041 +/- 534 dynes s-1 cm-5. On exercise, the left ventricular filling pressure fell from 33 +/- 6 to 26 +/- 3 and both cardiac index and stroke index increased by 13% and 16%, respectively. There was no significant change in heart rate or systemic blood pressure. In the patients with left ventricular dysfunction, coronary sinus blood flow increased from 107 +/- 11 to 133 +/- 12 ml/min but the increase in myocardial oxygen consumption was small and not significant (11.6 +/- 1.2 and 14.5 +/- 1.9 ml/min). In all patients there was no evidence that prenalterol was arrhythmogenic.

Adrenergic beta-Agonists↗
PubMed1982

Nonspecific suppressor cells in rheumatoid arthritis. Con A and PHA induced suppressor cell activity.

Suppression of the blastogenic response by autologous cells precultured with Concanavalin A (Con A) or Phytohemagglutinin (PHA) was studied in an in vitro system. The mean mitogen response of cells from normal individuals and from patients with Rheumatoid Arthritis (RA) in isologous plasma was similar. In isologous plasma there was no significant difference between the activity of Con A suppressor cells of normals and those of RA. Incubation of the cells in RA plasma abrogated the suppression in both normals and RA patients. In isologous plasma PHA suppressor cells were also induced in both groups, the levels being lower in the normals than in the RA group. PHA suppressor cell activity against PWM induced blastogenesis could not be engendered in normals. RA plasma abrogated PHA suppressor cell activity, especially in the RA group. The abrogating activity of RA plasma was heat stable, nondialysable and could be correlated with the presence of anti-lymphocyte antibodies in the RA plasma.

Arthritis, Rheumatoid↗
PubMed1981

The measurement of serum thyroglobulin in the presence of thyroglobulin antibodies.

In a significant proportion of patients with thyroid disorders, thyroglobulin antibodies (TgAb) invalidate double-antibody radioimmunoassays (RIA) for thyroglobulin (Tg). A modified RIA procedure for determining serum Tg in the presence of TgAb, is described. Two measurements are made on each sample. a Ratio of immunoglobulin (Ig)-bound thyroglobulin to free thyroglobulin (bound:free ratio). This is measured by the distribution of a trace quantity of 125I-Tg between bound and free fractions. b Concentration of free, i.e. unbound thyroglobulin. This is measured in the supernatant after precipitation of IgG-bound Tg. Then, bound Tg=B:F x (free Tg) and total Tg=(bound Tg)+(free Tg). Critical factors examined in the validation of the modified method were: (1) use of immunologically intact 125I-Tg (specific activity less than or equal to 5 mCi/mg); (2) equilibration of tracer Tg with endogenous serum Tg, and (3) clean separation of IgG-bound and free fractions of Tg with goat anti-human IgG. Recovery of added Tg in the presence of TgAb was 105% and interassay precision of total Tg assay was less than or equal to 9.3%. In euthyroid subjects without TgAb, the correlation between total Tg levels by the modified and standard double-antibody method was 0.931. The correlation was much poorer in the presence of TgAb (r=0.752) reflecting their interference in the standard method. Reference ranges for serum total Tg levels by the modified method in euthyroid, hyper- and hypothyroid subjects with and without TgAb are detailed.

Adolescent↗
PubMed1981

EEG differences between male alcoholics in withdrawal and those stabilized in treatment.

There is evidence that alcohol abuse and withdrawal produces cerebral impairment, some of which may be temporary and some permanent. This impairment has been found to be relatively specific in terms of brain areas affected. Recently our laboratory reported evidence that psychometrically measured impairment was systematically related to the energy in high frequency (beta-2) bands of the EEG. In the present study we attempted to determine the EEG patterns for male alcoholics undergoing withdrawal in comparison to patients who had been stabilized.

Alcohol Withdrawal Delirium↗
PubMed1980

Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes.

Urotensin II, a peptide hormone from the caudal neurosecretory system of the teleost, Gillichthys mirabilis, was isolated by using classical chromatographic techniques and high-performance liquid chromatography (HPLC). Direct microtechniques for sequence determination were used to establish its structure. Urotensin II from Gillichthys is a 1363-dalton dodecapeptide with the amino acid sequence Ala-Gly-Thr-Ala-Asp-Cys-Phe-Trp-Lys-Tyr-Cys-Val. This sequence is homologous with somatostatin in positions 1 and 2 and 7-9. The sequence has been verified by the production of a bioactive synthetic urotensin II. The possible chemical and physiological significance of its homology to somatostatin is discussed.

Amino Acid Sequence↗
PubMed1980

Radiotherapy and chemotherapy of limb tumours.

The place of radiotherapy and chemotherapy-separately, together, and in combination with surgery-in the treatment of limb tumours affecting skin, soft tissue, and bone is discussed.

Bone Neoplasms↗